The clinical trial of a Lassa fever candidate vaccine has begun enrolling participants at the University of Maryland School of Medicine, Baltimore. Lassa virus (a member of the Arenavirus family) ...

The CEPI-funded study will evaluate the safety, tolerability, and immunogenicity of IAVI's single dose Lassa fever vaccine candidate Key takeaways: Participants in Nigeria have been vaccinated with a ...

A National Institutes of Health (NIH)-sponsored clinical trial of a candidate vaccine to prevent Lassa fever has begun enrolling participants at the University of Maryland School of Medicine, ...

After more than 20 years of research on arenaviruses, an Institut Pasteur team led by Sylvain Baize has developed an original vaccine platform known as MOPEVAC, which will strengthen the Institut ...

The experimental vaccine is being developed by researchers at the University of Oxford, a UK-based research institution, with support from the Coalition for Epidemic Preparedness Innovations (CEPI).A ...

Thomas Jefferson University has initiated a phase 1 clinical trial for a Lassa virus (LASV) vaccine developed at Jefferson in collaboration with the University of Maryland, Baltimore (UMB), at the ...

Participants in Nigeria have been vaccinated with a Lassa fever vaccine candidate in the first Phase 2 clinical trial of any Lassa vaccine. Lassa fever is a deadly hemorrhagic fever common to West ...